[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,226,005
  • Shares Outstanding, K 113,498
  • Annual Sales, $ 1,397 M
  • Annual Income, $ 316,890 K
  • EBIT $ 746 M
  • EBITDA $ 838 M
  • 60-Month Beta 0.88
  • Price/Sales 8.65
  • Price/Cash Flow 22.32
  • Price/Book 88.00

Options Overview Details

View History
  • Implied Volatility 33.10% (+1.17%)
  • Historical Volatility 56.78%
  • IV Percentile 8%
  • IV Rank 13.68%
  • IV High 52.30% on 10/31/25
  • IV Low 30.06% on 08/26/26
  • Expected Move (DTE 16) 1.93 (1.78%)
  • Put/Call Vol Ratio 0.26
  • Today's Volume 44
  • Volume Avg (30-Day) 1,045
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 16,196
  • Open Int (30-Day) 18,083
  • Expected Range 106.43 to 110.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $2.04
  • Number of Estimates 3
  • High Estimate $2.21
  • Low Estimate $1.86
  • Prior Year $1.63
  • Growth Rate Est. (year over year) +25.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.75 +32.18%
on 08/04/26
109.66 -1.46%
on 08/26/26
+25.00 (+30.91%)
since 07/31/26
3-Month
66.00 +63.72%
on 06/03/26
109.66 -1.46%
on 08/26/26
+41.26 (+63.03%)
since 06/02/26
52-Week
61.22 +76.49%
on 12/11/25
109.66 -1.46%
on 08/26/26
+34.20 (+47.33%)
since 09/02/25

Most Recent Stories

More News
Halozyme to Participate at Upcoming Investor Conferences

SAN DIEGO , Sept. 2, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, and Darren Snellgrove,...

HALO : 108.46 (+0.69%)
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid

1 Mid-Cap Stock on Our Watchlist and 2 We Avoid

DCI : 90.12 (+0.40%)
VRSK : 188.52 (-3.00%)
HALO : 108.46 (+0.69%)
3 Market-Beating Stocks for Long-Term Investors

3 Market-Beating Stocks for Long-Term Investors

EVR : 288.68 (+0.86%)
CW : 566.87 (-1.92%)
HALO : 108.46 (+0.69%)
1 Healthcare Stock with Exciting Potential and 2 We Avoid

1 Healthcare Stock with Exciting Potential and 2 We Avoid

EHC : 121.37 (-0.56%)
WST : 341.28 (+0.78%)
HALO : 108.46 (+0.69%)
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges

2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges

BURL : 258.88 (-1.25%)
XPO : 187.45 (+1.28%)
HALO : 108.46 (+0.69%)
Halozyme Appoints Dannielle Appelhans to its Board of Directors

SAN DIEGO , Aug. 18, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced the election of Dannielle Appelhans to its Board of Directors. Ms. Appelhans brings...

HALO : 108.46 (+0.69%)
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call

The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call

HALO : 108.46 (+0.69%)
HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance

HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance

HALO : 108.46 (+0.69%)
Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

HALO : 108.46 (+0.69%)
1 Profitable Stock to Research Further and 2 We Ignore

1 Profitable Stock to Research Further and 2 We Ignore

MTN : 136.93 (+3.43%)
TTI : 6.60 (+1.07%)
HALO : 108.46 (+0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company...

See More

Key Turning Points

3rd Resistance Point 110.20
2nd Resistance Point 109.37
1st Resistance Point 108.54
Last Price 108.46
1st Support Level 106.88
2nd Support Level 106.05
3rd Support Level 105.22

See More

52-Week High 109.66
Last Price 108.46
Fibonacci 61.8% 91.16
Fibonacci 50% 85.44
Fibonacci 38.2% 79.73
52-Week Low 61.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.